Exome sequencing directly implicates 68 genes in inflammatory bowel disease

Large-scale whole-exome and whole-genome sequencing (86,213 IBD cases + 478,363 European controls) → direct identification of 68 genes through conditionally independent protein-coding associations

Analysis of whole-exome and whole-genome sequencing from 86,213 IBD cases and 478,363 European controls enables direct identification of 68 disease genes through conditionally independent protein-coding associations. Unlike classical GWAS, this approach directly resolves causal genes without ambiguity from non-coding localization. Non-additive effects and allelic series are described at NOD2 and TYK2 loci. Several newly implicated genes nominate therapeutically relevant targets with direct biological support.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

This massive cohort study represents a qualitative leap in IBD genetics: moving from non-coding variants (GWAS) to coding variants (large-scale WES/WGS) transforms associations into genes. Identifying 68 genes with direct biological relevance considerably accelerates the path to therapeutic hypotheses. Worth following closely for its peer-reviewed journal publication.

Clinical impact: 2/3 · Evidence strength: 3/3 · Novelty: 2/2 · Sample size: 1/1 · Journal quality: 0/1 · Preprint: -1 → Total: 7/10